386 ALOX12 polymorphisms are associated with fat mass in men W-J Xiao et al 18 Ku¨hn H, Barnett J, Grunberger D, Baecker P, Chow J, Nguyen B et al. Overexpression, purification and characterization of human recombinant 15-lipoxygenase. Biochim Biophys Acta 1993; 1169: 80–89. 19 Xiong DH, Shen H, Zhao LJ, Xiao P, Yang TL, Guo Y et al. Robust and comprehensive analysis of 20 osteoporosis candidate genes by very high-density single-nucleotide polymorphism screen among 405 white nuclear families identified significant association and gene-gene interaction. J Bone Miner Res 2006; 21: 1678–1695. 20 Mullin BH, Spector TD, Curtis CC, Ong GN, Hart DJ, Hakim AJ et al. Polymorphisms in ALOX12, but not ALOX15, are signi- ficantly associated with BMD in postmenopausal women. Calcif Tissue Int 2007; 81: 10–17. 21 Ichikawa S, Koller DL, Johnson ML, Lai D, Xuei X, Edenberg HJ et al. Human ALOX12, but not ALOX15, is associated with BMD in white men and women. J Bone Miner Res 2006; 21: 556–564. 22 Bleich D, Chen S, Zipser B, Sun D, Funk CD, Nadler JL. Resistance to type 1 diabetes induction in 12-lipoxygenase knockout mice. J Clin Invest 1999; 103: 1431–1436. 23 Huo Y, Zhao L, Hyman MC, Harry BL, Burcin T, Forlow SB et al. Critical role of macrophage 12/15-lipoxygenase for athero- sclerosis in apolipoprotein E-deficient mice. Circulation 2004; 110: 2024–2031. 24 Quintana LF, Guzman B, Collado S, Claria J, Poch E. A coding polymorphism in the 12-lipoxygenase gene is associated to essential hypertension and urinary 12(S)-HETE. Kidney Int 2006; 69: 526–530. 25 Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263–265. 26 Zhang ZL, He JW, Qin YJ, Hu YQ, Li M, Liu YJ et al. Association between SNP and haplotypes in PPARGC1 and adiponectin genes and bone mineral density in Chinese nuclear families. Acta Pharmacol Sin 2007; 28: 287–295. 27 Zhang ZL, He JW, Qin YJ, Hu YQ, Li M, Zhang H et al. Association between myostatin gene polymorphisms and peak BMD variation in Chinese nuclear families. Osteoporos Int 2008; 19: 39–47. 28 Abecasis GR, Cookson WO, Cardon LR. Pedigree tests of transmission disequilibrium. Eur J Hum Genet 2000; 8: 545–551. 29 Liu YJ, Liu PY, Long J, Lu Y, Elze L, Recker RR et al. Linkage and association analyses of the UCP3 gene with obesity phenotypes in Caucasian families. Physiol Genomics 2005; 22: 197–203. 30 Ode JJ, Pivarnik JM, Reeves MJ, Knous JL. Body mass index as a predictor of percent fat in college athletes and nonathletes. Med Sci Sport Exer 2007; 39: 403–409. 31 Flegal KM, Shepherd JA, Looker AC, Graubard BI, Borrud LG, Ogden CL et al. Comparisons of percentage body fat, body mass index, waist circumference, and waist-stature ratio in adults. Am J Clin Nutr 2009; 89: 500–508. 32 Liu X, Zhao LJ, Liu YJ, Xiong DH, Recker RR, Deng HW. The MTHFR gene polymorphism is associated with lean body mass but not fat body mass. Hum Genet 2008; 123: 189–196. 33 Sampath H, Ntambi JM. Polyunsaturated fatty acid regulation of genes of lipid metabolism. Ann Rev Nutr 2005; 25: 317–340. 34 Clarke SD. Polyunsaturated fatty acid regulation of gene transcription: a molecular mechanism to improve the metabolic syndrome. J Nutr 2001; 131: 1129–1132. International Journal of Obesity 35 Kadowaki T, Hara K, Yamauchi T, Terauchi Y, Tobe K, Nagai R. Molecular mechanism of insulin resistance and obesity. Exp Bio Med 2003; 228: 1111–1117. 36 Barroso I, Gurnell M, Crowley VE, Agostini M, Schwabe JW, Soos MA et al. Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 1999; 402: 880–883. 37 Mehrabian M, Schulthess FT, Nebohacova M, Castellani LW, Zhou Z, Hartiala J et al. Identification of ALOX5 as a gene regulating adiposity and pancreatic function. Diabetologia 2008; 51: 978–988. 38 Perusse L, Rankinen T, Zuberi A, Chagnon YC, Weisnagel SJ, Argyropoulos G et al. The human obesity gene map: the 2004 update. Obes Res 2005; 13: 381–490. 39 Laclaustra M, Corella D, Ordovas JM. Metabolic syndrome pathophysiology: the role of adipose tissue. Nutr Metab Cardiovasc Dis 2007; 17: 125–139. 40 Nishiyama M, Watanabe T, Ueda N, Tsukamoto H, Watanabe K. Arachidonate 12-lipoxygenase is localized in neurons, glial cells, and endothelial cells of the canine brain. J Histochem Cytochem 1993; 41: 111–117. 41 Nishiyama M, Okamoto H, Watanabe T, Hori T, Hada T, Ueda N et al. Localization of arachidonate 12-lipoxygenase in canine brain tissues. J Neurochem 1992; 58: 1395–1400. 42 Pratico D, Zhukareva V, Yao Y, Uryu K, Funk CD, Lawson JA et al. 12/15-lipoxygenase is increased in Alzheimer’s disease: possible involvement in brain oxidative stress. Am J Pathol 2004; 164: 1655–1662. 43 Yao Y, Clark CM, Trojanowski JQ, Lee VM, Pratico` D. Elevation of 12/15 lipoxygenase products in AD and mild cognitive impairment. Ann Neurol 2005; 58: 623–626. 44 Holguin F, Fitzpatrick A. Obesity, asthma, and oxidative stress. J Appl Physiol 2010; 108: 754–759. 45 Hopps E, Noto D, Caimi G, Averna MR. A novel component of the metabolic syndrome: the oxidative stress. Nutr Metab Cardiovasc Dis 2010; 20: 72–77. 46 Ioannidis JP, Ng MY, Sham PC, Zintzaras E, Lewis CM, Deng HW et al. Meta-analysis of genome-wide scans provides evidence for sex- and site-specific regulation of bone mass. J Bone Miner Res 2007; 22: 173–183. 47 Young D, Hopper JL, Macinnis RJ, Nowson CA, Hoang NH, Wark JD. Changes in body composition as determinants of longitudinal changes in bone mineral measures in 8 to 26-year-old female twins. Osteoporos Int 2001; 12: 506–515. 48 Reid IR. Relationships among body mass, its components, and bone. Bone 2002; 31: 547–555. 49 Hsu YH, Venners SA, Terwedow HA, Feng Y, Niu T, Li Z et al. Relation of body composition, fat mass, and serum lipids to osteoporotic fractures and bone mineral density in Chinese men and women. Am J Clin Nutr 2006; 83: 146–154. This work is licensed under the Creative Commons Attribution-NonCommercial-No Derivative Works 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/3.0/